Xenon Pharmaceuticals (XENE) Q4 2025 Earnings

3NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.15
-1.04
-0.94
-0.83

Details

Expected EPS
-1.152398
Actual EPS
-1.15
Surprise EPS
0
Surprise Percent
+0.21%

Description

Xenon Pharmaceuticals (XENE) has reported earnings of -1.15 per share for Q4 2025.

0 Comments

Share your thoughts